Skip to main content

Table 1 Baseline characteristics of the study population according to NAFLD and non-NAFLD, NHANES 2013–16

From: Serum glycolipids mediate the relationship of urinary bisphenols with NAFLD: analysis of a population-based, cross-sectional study

Variables

 

Total

  

Overall

Non-NAFLD

NAFLD

 

N = 960

N = 420

N = 540

p value

Age a

52.9 (17.3)

53.1 (18.5)

52.8 (16.3)

0.833

Sex, n(%)

   

0.063

 Female

516 (53.8%)

211 (50.4%)

305 (56.5%)

 

 Male

444 (46.2%)

209 (49.8%)

235 (43.5%)

 

Ethnicity, n(%)

   

 < 0.001

 Non-Hispanic White

367 (38.2%)

169 (40.2%)

198 (36.7%)

 

 Non-Hispanic Black

212 (22.1%)

73 (17.4%)

139 (25.7%)

 

 Non-Hispanic Asian

129 (13.4%)

96 (22.9%)

33 (6.11%)

 

 Mexican American

130 (13.6%)

36 (8.57%)

94 (17.4%)

 

 Other Hispanic

122 (12.7%)

46 (11.0%)

76 (14.1%)

 

Education, n(%)

   

0.001

 Less than high school

210 (21.9%)

75 (17.9%)

135 (25.0%)

 

 High school or equivalent

210 (21.9%)

80 (19.0%)

130 (24.1%)

 

 College or above

540 (56.2%)

265 (63.1%)

275 (50.9%)

 

Poverty income ratio

   

0.117

  < 1.0

209 (21.8%)

81 (19.3%)

128 (23.7%)

 

  ≥ 1.0

751 (78.2%)

339 (80.7%)

412 (76.3%)

 

Smoking, n(%)

   

0.906

 never

596 (62.1%)

261 (62.3%)

335 (62.0%)

 

 former

229 (23.9%)

98 (23.3%)

131 (24.3%)

 

 current

135 (14.1%)

61 (14.5%)

74 (13.7%)

 

Drinking, n(%)

   

0.345

 No or unknown

293 (30.6%)

121 (28.8%)

172 (31.9%)

 

 Yes

667 (69.5%)

299 (71.2%)

368 (68.1%)

 

Hypertension, n(%)

   

 < 0.001

 No

504 (52.5%)

260 (61.9%)

244 (45.2%)

 

 Yes

456 (47.5%)

160 (38.1%)

296 (54.8%)

 

Diabetes, n(%)

   

 < 0.001

 No

722 (75.2%)

366 (87.1%)

356 (65.9%)

 

 Yes

238 (24.8%)

54 (12.9%)

184 (34.1%)

 

 BMI, (kg/m2) a

29.3 (7.08)

23.8 (2.92)

33.6 (6.35)

 < 0.001

 TC, (mg/dL) a

188 (39.7)

188 (39.4)

188 (39.9)

0.910

 TG, (mg/dL) b

94.0 [63.0;136]

80.0 [56.0;112]

108 [74.0;155]

 < 0.001

 LDL-C, (mg/dL) a

112 (34.8)

109 (33.7)

113 (35.7)

0.083

 HDL-C, (mg/dL) a

54.6 (16.1)

60.1 (17.5)

50.4 (13.5)

 < 0.001

 Glucose, (mg/dL) a

111 (37.4)

102 (25.6)

119 (43.1)

 < 0.001

 HbA1c (%) a

5.92 (1.26)

5.60 (0.87)

6.16 (1.45)

 < 0.001

 Urinary BPA, (ng/mL) b

1.10 [0.50;2.20]

0.90 [0.50;2.00]

1.25 [0.60;2.32]

0.001

 Urinary BPS, (ng/mL) b

0.50 [0.20;1.20]

0.40 [0.20;0.95]

0.60 [0.20;1.33]

 < 0.001

 Urinary BPF, (ng/mL) b

0.25 [0.14;0.80]

0.20 [0.14;0.70]

0.30 [0.14;0.80]

0.231

 HSI a

38.5 (8.20)

31.5 (3.07)

43.9 (6.65)

 < 0.001

  1. a data is expressed with mean (SD)
  2. b data is expressed with median [IQR]. NHANES National Health and Nutrition Examination Survey, NAFLD non-alcoholic fatty liver disease, SD standard deviation, IQR interquartile range, BMI body mass index, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, HbA1c glycosylated hemoglobin A1c, BPA bisphenol A, BPS bisphenol S, BPF bisphenol F, HSI hepatic steatosis index, p < 0.05 suggests significant differences